Shipping & Receiving Associate

Job Description Job Description Entry-level temporary position responsible for packing and shipping customer orders, receiving inbound materials, and supporting inventory cycle counts in a regulated medical device environment.

Responsibilities
• Pack and ship customer orders accurately and on time using FedEx/UPS shipping software
• Receive inbound shipments; inspect, document, and put away materials
• Generate shipping labels and enter transactions into ERP/computer system
• Perform inventory cycle counts
• Operate hand truck; forklift use a plus
• Maintain cleanliness and organization of shipping/receiving area
• Follow current SOPs and quality system requirements (ISO/FDA regulated environment)

Requirements
• Basic computer skills
• Ability to lift up to 50 lbs
• Ability to follow written instructions and procedures
• Reliable and able to work independently with minimal supervision
• FedEx/UPS shipping software experience a plus
• Forklift certification a plus

Reports To: Logistics & Packaging Manager
Company Description Qualigen is a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics. The FastPack® line of FDA-cleared and CE-Marked products has been used successfully in diagnostics since 2002. Our therapeutics pipeline includes cancer drug compounds such as QN-302, RAS, QN-247, as well as STARS, a DNA/RNA-based treatment device. By combining our demonstrated ability to develop and commercialize innovative medical products with the advanced capabilities of leading cancer research centers, such as the University of Louisville, we are committed to providing exciting new therapeutic technologies to physicians and patients. Company Description Qualigen is a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics. The FastPack® line of FDA-cleared and CE-Marked products has been used successfully in diagnostics since 2002. Our therapeutics pipeline includes cancer drug compounds such as QN-302, RAS, QN-247, as well as STARS, a DNA/RNA-based treatment device. By combining our demonstrated ability to develop and commercialize innovative medical products with the advanced capabilities of leading cancer research centers, such as the University of Louisville, we are committed to providing exciting new therapeutic technologies to physicians and patients.